Intracranial Pressure Monitoring Market Size To Reach USD 1.97 Billion By 2026 – Top Key Players Medtronic Plc., RAUMEDIC Inc., Integra LifeSciences Corporation

High prevalence of incidences of traumatic brain injury, increasing awareness about minimally invasive techniques, escalation in the technological advancements in the field of Intracranial Pressure Monitoring are key factors contributing to high CAGR in the forecast period.

According to the current analysis of Reports and Data, the global Intracranial Pressure Monitoring market was valued at USD 1.19 billion in 2018 and is expected to reach USD 1.97 billion by the year 2026, at a CAGR of 6.5%. Intracranial pressure monitoring (ICP) involves measuring the pressure in the skull by placing a small probe inside the skull, which is attached to the other end to a bedside monitor. The device senses the pressure inside the skull and sends the measurements to a recording device and hence can be compared with the normal range of the pressure inside the skull. The monitoring of intracranial pressure is used in treating various severe traumatic brain injuries, neurodegenerative diseases, and others.

The key aspects acting as the growth factors include the rising prevalence of neurological disorders and traumatic accidents, which are anticipated to propel the market of intracranial pressure monitoring devices in the forecast period. For instance, according to the World Health Organization 2018, it is estimated that about sixty-nine million individuals worldwide are expected to sustain a Traumatic Brain Injury each year. Furthermore, escalating cases of brain infection, aneurysm, and meningitis would result in an amplified requirement for ICP monitoring. An increase in the spending capacity of the individuals for the health care system is affecting boosting the market growth in the forecast period. For instance, according to the database of the World Health Organization, 2019 the two years into the Sustainable Development Goals era, global spending on health continues to rise which was US$ 7.8 trillion in 2017, suggesting about 10% of GDP and $1,080 per capita which has increased up from US$ 7.6 trillion in 2016. Moreover, the stringent regulation and the growing product recalls are anticipated to hamper the growth of the market in the coming years.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2653

Market Dynamics:

Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.

Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2026.

Competitive Outlook:

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.

Further key findings from the report suggest

• According to the World Health Organization 2018, it is estimated that about sixty-nine million individuals worldwide are expected to sustain a Traumatic Brain Injury each year. The growing rates of traumatic injuries are calculated to propel the market in the near future.

• The stringent regulations of the market would decide the market growth in the forecast period. For instance, the U.S. Food and Drug Administration (FDA) in May 2019, announced a class I recall of Integra LifeSciences’ LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System and its MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring Systems. A class I recall is the most severe type of recall in which the recalled product poses a grave risk of harm or death to the patient. The stringent regulations over the products would help the right quality products to grow in the forecast period.

• The key players in this sector are focusing more on technological advancements. For instance, Raumedic has recently launched an intracranial pressure monitoring device for home use. The telemetric catheter, the device called Raumed Home ICP, measures the pressure inside the cranium – the intracranial pressure, or ICP. The product has recently received CE marking and was developed primarily for people who suffer from hydrocephalus.

• The recent innovation in the intracranial pressure monitoring device includes the change in bioresorbable optical sensor systems, which uses millimeter-scale and bioresorbable Fabry-Perot interferometers and two-dimensional photonic crystal structures enabling accurate, continuous measurements of pressure and temperature.

• Among the key market players, Branchpoint Technologies in 2018 announced that the United States Food and Drug Administration (FDA) had granted 510(k) clearance for its AURA ICP Monitoring System. It includes a fully implantable and wireless intracranial pressure (ICP) sensor, which enables mobile ICP monitoring in brain-injured patients. The AURA system is entirely wireless in both the power and transmission of patient data directly to a bedside monitor. AURA enables telemetric monitoring of parenchymal ICP, including continuous ICP waveforms, and eliminates the need for additional capital equipment investments.

• The global Intracranial Pressure Monitoring market is highly fragmented with major players like Medtronic Plc. (Ireland), RAUMEDIC Inc. (Germany), Integra LifeSciences Corporation (US), DePuy Synthes (US), Codman and Shurtleff , Inc., Vittamed, Spiegelberg GmbH & Co. KG (Germany), Sophysa SA (France), Orsan Medical Technologies, Boston Neurosciences (US), Terumo Corporation (US), and Natus Medical Incorporated (US).

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2653

For the purpose of this report, Reports and Data has segmented the Intracranial Pressure Monitoring market on the basis of techniques, applications, end-use and region:

Techniques Outlook (Revenue in Million USD; 2016–2026)

• Invasive
o External Ventricular Drainage
o Microtransducer ICP Monitoring Devices
 Fibre Optic Devices
 Microchips
 Others
• Non-invasive
o MRI/CT
o Fundoscopy
o Transcranial Doppler Ultrasonography
o Tymphanic Membrane Displacements
o Others

Applications Outlook (Revenue in Million USD; 2016–2026)

• Intracerebral Hemorrhage
• Traumatic Brain Surgery
• Meningitis
• Subarachnoid Hemorrhage
• CNS Infections
• Cerebral Edema
• Others

End-Use Outlook (Revenue in Million USD; 2016–2026)

• Hospitals
• Clinics
• Trauma Centers
• Ambulatory Surgical Centers
• Specialty Centers
• Others

Regional Outlook (Revenue in Million USD; 2016–2026)

• North America
o U.S
o Canada
• Europe
o Germany
o France
o UK
o Spain
o Italy
o Rest of the Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
• Latin America
o Brazil

The report segments the Intracranial Pressure Monitoring market on the basis of product types, applications, end-use industries, and regions among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2653

Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized as per your requirements.

Read More Reports:-

Bioreactors and Fermenters Market @ https://www.google.bf/url?q=https://www.reportsanddata.com/report-detail/bioreactors-and-fermenters-market

Healthcare Workforce Management System Market @ https://www.google.gy/url?q=https://www.reportsanddata.com/report-detail/healthcare-workforce-management-system-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.